Compared with the two-probe method, we believe that the four-probe measurement can further reveal the intrinsic electronic transport properties of the nanowires.
Because of the good biocompatibility, high chemical stability and simple fabrication method, we believe that our results will contribute to the current endeavors aimed at building blocks of nanostructured devices as violet light sources and developing new biological probes in life science.
Given the robustness of our differentiation method, we believe the hESC-CM population would be an ideal source of replacement cells in the in vivo setting.
Rather than using standard data compression method, we believe that a fruitful option could be the development of data compression tools specifically adapted to the very nature of the measured force curves.
An additional strength of this method we believe to be the role of the experts.
Based on the characteristics of the method, we believe it has potential as a means of assessing the impact on physician recommendations of decision support tools.
Even though only petal cells were visualized with this method, we believe this method is applicable to a wide range of tissues (such as leaves, sepals, and stamens), as well as a wider range of angiosperm diversity than presented here.
Although subsequent work has improved upon the SGPP method through different variants of the method, we believe if similar variations were to be applied to the GCPV method, its performance would improve similarly.
However, as the magnitude of measurable BMD loss during pregnancy was substantial larger (5-75-7%han the projected least significant change (LSC) that could be measured with the method, we believe that such measurements should be valid.
With the current attention focused on the CTG+ST fetal surveillance method, we believe that a thorough review of the quality of the original five randomized controlled trials (RCTs) 12– 16 was warranted, as well as a critical review of the quality of the five MAs that have followed 1– 5.
